Edition:
India

Sino Biopharmaceutical Says Anlotinib Hydrochloride Capsules Obtained Approval For New Indication


Friday, 5 Jul 2019 

July 5 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::ANLOTINIB HYDROCHLORIDE CAPSULES GOT APPROVAL FOR DRUG REGISTRATION FOR NEW INDICATION FOR TREATMENT OF "SOFT TISSUE SARCOMA".APPROVAL FOR DRUG REGISTRATION GRANTED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PRC. 

Company Quote

10.78
0.22 +2.08%
23 Aug 2019